AltMountain

Oaktree Life Sciences Lending Fund, L.P.

Los Angeles, CA · CIK 1879547
Status: no Form D since Nov 2022. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Oaktree Life Sciences Lending Fund, L.P. is a private equity fund based in Los Angeles, California. According to its most recent Form D, filed Nov 1, 2022, it has sold $164,490,000 of interests to 37 investors since its first sale in Oct 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Bruce Karsh; Jay Wintrob; Howard Marks.

Total raised
$164,490,000Cumulative sales reported on Form D
Investors
37
First sale
Oct 27, 2021
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Bruce Karsh; Jay Wintrob; Howard Marks
Latest Form D
Nov 1, 2022

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Nov 1, 2022Form D/A (amendment)$164,490,00037SEC.gov ↗
Sep 3, 2021Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 3, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Vehicles of this fund (3)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
Oaktree Life Sciences Lending Fund, L.P. (main vehicle on this page)1879547Los Angeles, California$164,490,00037$0Nov 1, 2022
Oaktree Life Sciences Lending Fund (Parallel), L.P.1879382Los Angeles, California$33,100,00011$0Nov 1, 2022
Oaktree Life Sciences Lending Fund Feeder Cayman (Parallel), L.P.1879380Los Angeles, California$19,000,0004$0Nov 1, 2022

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 3 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Oaktree Life Sciences Lending Fund, L.P., the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Raise history: Oaktree Life Sciences Lending Fund (Parallel), L.P.

FiledFilingTotal raisedInvestorsSource
Nov 1, 2022Form D/A (amendment)$33,100,00011SEC.gov ↗
Sep 3, 2021Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 3, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Raise history: Oaktree Life Sciences Lending Fund Feeder Cayman (Parallel), L.P.

FiledFilingTotal raisedInvestorsSource
Nov 1, 2022Form D/A (amendment)$19,000,0004SEC.gov ↗
Sep 3, 2021Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 3, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Foundations that report holding this fund

FoundationStateValue reportedBasisTax year ended
Joyce and Irving Goldman FamilyNY$437,404fair market valueDec 31, 2024

1 private foundation listed this fund by name among the investments on its IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.

Questions about Oaktree Life Sciences Lending Fund, L.P.

What is the minimum investment for Oaktree Life Sciences Lending Fund, L.P.?

Oaktree Life Sciences Lending Fund, L.P.'s latest Form D, filed Nov 1, 2022, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Oaktree Life Sciences Lending Fund, L.P.?

Oaktree Life Sciences Lending Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Oaktree Life Sciences Lending Fund, L.P. raised?

Oaktree Life Sciences Lending Fund, L.P. reports $164,490,000 sold from 37 investors on its Form D filed Nov 1, 2022. This is cumulative sales since the offering began, not current assets or performance.

Where is Oaktree Life Sciences Lending Fund, L.P. based?

Oaktree Life Sciences Lending Fund, L.P. is based in Los Angeles, California.

When did Oaktree Life Sciences Lending Fund, L.P. launch?

Oaktree Life Sciences Lending Fund, L.P. reports its first sale in Oct 2021.

Size compared with every private equity fund

Raised more than 91% of the 1,741 private equity funds based in California, and more than 79% of all 8,931 that report sales.

Other funds with the same team

More private equity funds in Los Angeles

Similar-size private equity funds in California

All private equity funds in California